Quotient acquisition of Arcinova aimed at ‘streamlining’ early development process for biotech and pharma companies

Quotient acquisition of Arcinova aimed at ‘streamlining’ early development process for biotech and pharma companies

Submitted by admin on February 18, 2021 - 10:43am
Source: 
Biopharma Reporter
News Tags: 
Quotient
M&A
Arcinova
CDMOs
Headline: 
Quotient acquisition of Arcinova aimed at ‘streamlining’ early development process for biotech and pharma companies
snippet: 

Quotient Sciences, a drug development and manufacturing accelerator with facilities in the UK and the US, has acquired Arcinova, a UK-based multiservice contract development and manufacturing organization (CDMO).

Do Not Allow Advertisers to Use My Personal information